CAMP4 Therapeutics (CAMP) vs Vogenx (VOGX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CAMP4 Therapeutics is the larger company by market cap ($241.0 million vs $240.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CAMP | VOGX |
|---|---|---|
| Share price | $3.84 | $16.16 |
| Market cap | $240.97M | $240.06M |
| 1-day change | -3.03% | -1.40% |
| YTD return | -37.36% | — |
| 1-year return | +16.72% | — |
| EPS (TTM) | $-2.32 | $-0.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.75 | $38.41 |
| 52-week low | $2.86 | $12.95 |
| Distance from 52-week high | -50.45% | -57.93% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +175.26% | +240.35% |
| Average volume | 279.95K | 187.53K |
| Shares outstanding | 62.75M | 14.86M |
| Employees | 48 | 4 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About CAMP4 Therapeutics
CAMP stock →Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders.
Healthcare · Biotechnology · 48 employees
About Vogenx
VOGX stock →Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis.
Healthcare · Biotechnology · 4 employees
CAMP vs VOGX FAQ
Which is bigger, CAMP4 Therapeutics or Vogenx?
CAMP4 Therapeutics (CAMP) is larger, with a market capitalization of $240.97M compared with $240.06M for Vogenx (VOGX).
Are CAMP4 Therapeutics and Vogenx in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.